Meetings of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 83560-83561 [2023-26320]
Download as PDF
<![CDATA[
83560
Federal Register / Vol. 88, No. 229 / Thursday, November 30, 2023 / Notices
Dated: November 24, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
meeting virtually will be posted at least
one week prior to the meeting at: https://
www.hhs.gov/paccarb.
[FR Doc. 2023–26358 Filed 11–29–23; 8:45 am]
FOR FURTHER INFORMATION CONTACT:
BILLING CODE 4164–01–P
Jomana Musmar, M.S., Ph.D.,
Designated Federal Officer, Presidential
Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of
the Assistant Secretary for Health, U.S.
Department of Health and Human
Services, 1101 Wootton Parkway,
Rockville, MD 20852. Phone: 202–746–
1512; Email: CARB@hhs.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meetings of the Presidential Advisory
Council on Combating AntibioticResistant Bacteria
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that a virtual meeting is scheduled to be
held for the Presidential Advisory
Council on Combating AntibioticResistant Bacteria (PACCARB). The
meeting will be open to the public and
will be streamed live on hhs.gov/live. A
pre-registered public comment session
will be held during the meeting. Preregistration is required for members of
the public who wish to present their
comments live during the virtual
meeting. Individuals who wish to
provide written public comment should
send an email to CARB@hhs.gov that
includes their written comments.
Registration information is available on
the website https://www.hhs.gov/paccarb
and should be completed by December
18, 2023 for the December 20, 2023
virtual Public Meeting. Additional
information about registering for the
meeting and providing public comment
can be obtained at https://www.hhs.gov/
paccarb on the Upcoming Meetings
page. HHS is also giving notice of the
appointment of 16 new PACCARB
councilmembers that will be sworn-in
in preparation of the December 20, 2023
virtual public meeting.
DATES: The meeting is scheduled to be
held on December 20, 2023, from 9 a.m.
to 4 p.m. ET (times are tentative and
subject to change). The confirmed times
and agenda items for the meeting will be
posted on the website for the PACCARB
at https://www.hhs.gov/paccarb when
this information becomes available. Preregistration for attending the meeting is
strongly suggested and should be
completed no later than December 18,
2023.
ADDRESSES: The virtual meeting can be
accessed through a live webcast on the
day of the meeting. Additional
instructions regarding attending this
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:22 Nov 29, 2023
Jkt 262001
The
Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria
(PACCARB), established by Executive
Order 13676, is continued by section
505 of Public Law 116–22, the
Pandemic and All-Hazards
Preparedness and Advancing Innovation
Act of 2019 (PAHPAIA). Activities and
duties of the PACCARB are governed by
the provisions of the Federal Advisory
Committee Act (FACA), Public Law 92–
463, as amended (5 U.S.C. app.), which
sets forth standards for the formation
and use of federal advisory committees.
The PACCARB shall advise and
provide information and
recommendations to the Secretary of
Health and Human Services (Secretary)
regarding programs and policies
intended to reduce or combat antibioticresistant bacteria that may present a
public health threat and improve
capabilities to prevent, diagnose,
mitigate, or treat such resistance. The
PACCARB shall function solely for
advisory purposes.
Such advice, information, and
recommendations may be related to
improving: the effectiveness of
antibiotics; research and advanced
research on, and the development of,
improved and innovative methods for
combating or reducing antibiotic
resistance, including new treatments,
rapid point-of-care diagnostics,
alternatives to antibiotics, including
alternatives to animal antibiotics, and
antimicrobial stewardship activities;
surveillance of antibiotic-resistant
bacterial infections, including publicly
available and up-to-date information on
resistance to antibiotics; education for
health care providers and the public
with respect to up-to-date information
on antibiotic resistance and ways to
reduce or combat such resistance to
antibiotics related to humans and
animals; methods to prevent or reduce
the transmission of antibiotic-resistant
bacterial infections; including
stewardship programs; and coordination
with respect to international efforts in
order to inform and advance the United
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
States capabilities to combat antibiotic
resistance.
The Advisory Council is authorized to
consist of at least 30 members,
including the voting and non-voting
members and the Chair and Vice Chair.
The current composition of the
Advisory Council consists of 15 voting
members, including the Chair and Vice
Chair, eight non-voting liaison
representative members, and 12 nonvoting ex-officio members. In March of
2023, the terms of 16 councilmembers
ended, and an announcement was
published August 1, 2022 and closed on
September 19, 2022 to solicit
nominations to fill the open PACCARB
positions, nine of which were in the
voting member category, including the
Chair and Vice-Chair positions, while
the remaining seven were in the nonvoting liaison member category. These
positions have been filled and the new
PACCARB members will be sworn-in in
preparation for the December 20, 2023,
virtual public meeting. Newly
appointed voting members were
selected to serve four-year terms, and
non-voting liaison members were
appointed to serve for two-year terms.
The full roster of councilmembers,
including the 16 new members, can be
found on the Membership page at https://
www.hhs.gov/paccarb.
The December 20, 2023, virtual public
meeting will be dedicated to current
global U.S. federal efforts to combat
antimicrobial resistance in response to a
task from the Secretary given to the
PACCARB in 2023. The signed task
letter from the Secretary can be found at
https://www.hhs.gov/paccarb. The
meeting agenda will be posted on the
PACCARB website at https://
www.hhs.gov/paccarb when it has been
finalized. All agenda items and times
are tentative and subject to change.
Instructions regarding attending the
meeting virtually will be posted at least
one week prior to the meeting at: https://
www.hhs.gov/paccarb.
Members of the public will have the
opportunity to provide comments
during the December meeting by preregistering online at https://
www.hhs.gov/paccarb. Pre-registration
is required for participation in this
session with limited spots available.
Written public comments can also be
emailed to CARB@hhs.gov by midnight
December 18, 2023 and should be
limited to no more than one page. All
public comments received prior to
December 18, 2023, will be provided to
the PACCARB members. Additionally,
companies and/or organizations
involved in combating antibiotic
resistance have an opportunity to
present their work to members of the
E:\FR\FM\30NON1.SGM
30NON1
Federal Register / Vol. 88, No. 229 / Thursday, November 30, 2023 / Notices
PACCARB live during an Innovation
Spotlight. Pre-registration is required for
participation, with limited spots
available. All information regarding this
session can also be found online at
https://www.hhs.gov/paccarb.
Dated: November 9, 2023.
Jomana F. Musmar,
Designated Federal Officer, Presidential
Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant
Secretary for Health.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Instrumentation, Assay
Development and Cellular Biology.
Date: December 15, 2023.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joonil Seog, SCD Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, 301–402–9791,
joonil.seog@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Jkt 262001
[FR Doc. 2023–26264 Filed 11–29–23; 8:45 am]
[Docket Number: USCG–2023–0825]
Coast Guard
BILLING CODE 4140–01–P
National Institutes of Health
BILLING CODE 4150–44–P
17:22 Nov 29, 2023
DEPARTMENT OF HOMELAND
SECURITY
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2023–26320 Filed 11–29–23; 8:45 am]
VerDate Sep<11>2014
Dated: November 24, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
83561
Designation of the Coast Guard
Academy Athletics Corporation as a
Qualified Organization and
Appointment of Dr. Daniel Rose as a
Member of the Board of Directors of
the Corporation
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
AGENCY:
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
SUMMARY:
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Time-Sensitive
Obesity Review.
Date: December 18, 2023.
Time: 3:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
Division of Extramural Activities, NIDDK,
National Institutes of Health, Room 7353,
6707 Democracy Boulevard, Bethesda, MD
20892–2542, (301) 594–8898, barnardm@
extra.niddk.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: November 27, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–26361 Filed 11–29–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
Coast Guard, Department of
Homeland Security (DHS).
ACTION: Notice.
The Coast Guard announces
the designation of the Coast Guard
Academy Athletics Corporation
(CGAAC) as a qualified non-Federal
entity that can receive support from the
Federal Government. Dr. Daniel Rose,
Athletics Director of the Coast Guard
Academy, has been appointed to serve
as a member on the Board of Directors
of the CGAAC. Dr. Rose will provide
oversight of, advice to, and coordination
with, the CGAAC. Dr. Rose will not
participate in the day-to-day operations
of the CGAAC.
DATES: The appointment was made
October 19, 2023.
ADDRESSES: To view documents
mentioned in this preamble as being
available in the docket, go to https://
www.regulations.gov, type USCG–2023–
0825 in the search box and click
‘‘Search.’’ Next, in the Document Type
column, select ‘‘Supporting & Related
Material.’’
FOR FURTHER INFORMATION CONTACT: If
you have questions on this rule, call or
email Commander Jeffrey G. Janaro,
Coast Guard Academy, telephone 860–
444–8255, email jeff.g.janaro@uscg.mil.
SUPPLEMENTARY INFORMATION: The Coast
Guard announces the designation of the
Coast Guard Academy Athletics
Corporation (CGAAC) as a ‘‘qualified
organization’’ under 14 U.S.C. 953.
Section 953 allows the Coast Guard
Academy Alumni Association to
establish a ‘‘qualified organization’’
solely for the purpose of supporting
Coast Guard athletics.
A ‘‘qualified organization’’ means an
organization (1) that operates as an
organization under subsection (c)(3) of
section 501 of the Internal Revenue
Code of 1986 and exempt from taxation
under subsection (a) of that section; (2)
for which authorization under sections
1033(a) and 1589(a) of Title 10 may be
provided; and (3) established by the
Coast Guard Academy Alumni
Association solely for the purpose of
supporting Coast Guard athletics.
E:\FR\FM\30NON1.SGM
30NON1
]]>Agencies
[Federal Register Volume 88, Number 229 (Thursday, November 30, 2023)]
[Notices]
[Pages 83560-83561]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-26320]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meetings of the Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that a virtual meeting is scheduled to be held for the Presidential
Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB).
The meeting will be open to the public and will be streamed live on
hhs.gov/live. A pre-registered public comment session will be held
during the meeting. Pre-registration is required for members of the
public who wish to present their comments live during the virtual
meeting. Individuals who wish to provide written public comment should
send an email to [email protected] that includes their written comments.
Registration information is available on the website https://www.hhs.gov/paccarb and should be completed by December 18, 2023 for
the December 20, 2023 virtual Public Meeting. Additional information
about registering for the meeting and providing public comment can be
obtained at https://www.hhs.gov/paccarb on the Upcoming Meetings page.
HHS is also giving notice of the appointment of 16 new PACCARB
councilmembers that will be sworn-in in preparation of the December 20,
2023 virtual public meeting.
DATES: The meeting is scheduled to be held on December 20, 2023, from 9
a.m. to 4 p.m. ET (times are tentative and subject to change). The
confirmed times and agenda items for the meeting will be posted on the
website for the PACCARB at https://www.hhs.gov/paccarb when this
information becomes available. Pre-registration for attending the
meeting is strongly suggested and should be completed no later than
December 18, 2023.
ADDRESSES: The virtual meeting can be accessed through a live webcast
on the day of the meeting. Additional instructions regarding attending
this meeting virtually will be posted at least one week prior to the
meeting at: https://www.hhs.gov/paccarb.
FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S.
Department of Health and Human Services, 1101 Wootton Parkway,
Rockville, MD 20852. Phone: 202-746-1512; Email: [email protected].
SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria (PACCARB), established by
Executive Order 13676, is continued by section 505 of Public Law 116-
22, the Pandemic and All-Hazards Preparedness and Advancing Innovation
Act of 2019 (PAHPAIA). Activities and duties of the PACCARB are
governed by the provisions of the Federal Advisory Committee Act
(FACA), Public Law 92-463, as amended (5 U.S.C. app.), which sets forth
standards for the formation and use of federal advisory committees.
The PACCARB shall advise and provide information and
recommendations to the Secretary of Health and Human Services
(Secretary) regarding programs and policies intended to reduce or
combat antibiotic-resistant bacteria that may present a public health
threat and improve capabilities to prevent, diagnose, mitigate, or
treat such resistance. The PACCARB shall function solely for advisory
purposes.
Such advice, information, and recommendations may be related to
improving: the effectiveness of antibiotics; research and advanced
research on, and the development of, improved and innovative methods
for combating or reducing antibiotic resistance, including new
treatments, rapid point-of-care diagnostics, alternatives to
antibiotics, including alternatives to animal antibiotics, and
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health
care providers and the public with respect to up-to-date information on
antibiotic resistance and ways to reduce or combat such resistance to
antibiotics related to humans and animals; methods to prevent or reduce
the transmission of antibiotic-resistant bacterial infections;
including stewardship programs; and coordination with respect to
international efforts in order to inform and advance the United States
capabilities to combat antibiotic resistance.
The Advisory Council is authorized to consist of at least 30
members, including the voting and non-voting members and the Chair and
Vice Chair. The current composition of the Advisory Council consists of
15 voting members, including the Chair and Vice Chair, eight non-voting
liaison representative members, and 12 non-voting ex-officio members.
In March of 2023, the terms of 16 councilmembers ended, and an
announcement was published August 1, 2022 and closed on September 19,
2022 to solicit nominations to fill the open PACCARB positions, nine of
which were in the voting member category, including the Chair and Vice-
Chair positions, while the remaining seven were in the non-voting
liaison member category. These positions have been filled and the new
PACCARB members will be sworn-in in preparation for the December 20,
2023, virtual public meeting. Newly appointed voting members were
selected to serve four-year terms, and non-voting liaison members were
appointed to serve for two-year terms. The full roster of
councilmembers, including the 16 new members, can be found on the
Membership page at https://www.hhs.gov/paccarb.
The December 20, 2023, virtual public meeting will be dedicated to
current global U.S. federal efforts to combat antimicrobial resistance
in response to a task from the Secretary given to the PACCARB in 2023.
The signed task letter from the Secretary can be found at https://www.hhs.gov/paccarb. The meeting agenda will be posted on the PACCARB
website at https://www.hhs.gov/paccarb when it has been finalized. All
agenda items and times are tentative and subject to change.
Instructions regarding attending the meeting virtually will be posted
at least one week prior to the meeting at: https://www.hhs.gov/paccarb.
Members of the public will have the opportunity to provide comments
during the December meeting by pre-registering online at https://www.hhs.gov/paccarb. Pre-registration is required for participation in
this session with limited spots available. Written public comments can
also be emailed to [email protected] by midnight December 18, 2023 and
should be limited to no more than one page. All public comments
received prior to December 18, 2023, will be provided to the PACCARB
members. Additionally, companies and/or organizations involved in
combating antibiotic resistance have an opportunity to present their
work to members of the
[[Page 83561]]
PACCARB live during an Innovation Spotlight. Pre-registration is
required for participation, with limited spots available. All
information regarding this session can also be found online at https://www.hhs.gov/paccarb.
Dated: November 9, 2023.
Jomana F. Musmar,
Designated Federal Officer, Presidential Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for
Health.
[FR Doc. 2023-26320 Filed 11-29-23; 8:45 am]
BILLING CODE 4150-44-P
